Collagenase clostridium histolyticum: a novel nonsurgical option for the treatment of Peyronie’s disease

Author： Aliperti Louis A Trost Landon W Hellstrom Wayne JG

ISSN： 1758-4272

Source： International Journal of Clinical Rheumatology, Vol.8, Iss.5, 2013-10, pp. : 531-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie’s disease: a study of 151 cases

By Paulis G. D’Ascenzo R. Nupieri P. De Giorgio G. Orsolini G. Brancato T. Alvaro R.

International Journal of Andrology, Vol. 35, Iss. 4, 2012-08 ,pp. : 521-527

Blackwell Publishing

Access to resources Recommend Favorite

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial

By Palmieri A. Imbimbo C. Creta M. Verze P. Fusco F. Mirone V.

International Journal of Andrology, Vol. 35, Iss. 2, 2012-04 ,pp. : 190-195

Blackwell Publishing

Access to resources Recommend Favorite

Antiangiogenic agents in advanced, persistent or recurrent endometrial cancer: a novel treatment option

By Gadducci Angiolo Sergiampietri Claudia Guiggi Ilaria

Gynecological Endocrinology, Vol. 29, Iss. 9, 2013-09 ,pp. : 811-816

Informa Healthcare

Access to resources Recommend Favorite

Editorial [ Angiogenesis: A Promising Treatment Option for Peripheral Arterial Disease ]

Current Vascular Pharmacology, Vol. 6, Iss. 2, 2008-04 ,pp. : 78-80

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Studies with a Dual-Release Formulation of Levodopa, a Novel Principle in the Treatment of Parkinson’s Disease

European Neurology, Vol. 39, Iss. 2, 1998-02 ,pp. : 119-124

Karger

Access to resources Recommend Favorite